tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Arteris Stock (AIP) Jumps 56% Ahead of Q2 Earnings on Licensing Deal with Chip Giant AMD

Story Highlights

Arteris (AIP) stock rallied about 56% in Monday’s extended trading session following the announcement of a licensing deal with Advanced Micro Devices (AMD).

Arteris Stock (AIP) Jumps 56% Ahead of Q2 Earnings on Licensing Deal with Chip Giant AMD

Arteris (AIP) stock rallied about 56% in Monday’s extended trading session after announcing a licensing deal with chip giant Advanced Micro Devices (AMD). Specifically, Arteris stated that AMD licensed its FlexGen network-on-chip (NoC) interconnect IP (intellectual property) for its next generation of AI chiplet design.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Arteris offers system IP that is used in semiconductors to accelerate the creation of high-performance, power-efficient silicon.

Arteris Expected to Gain from AMD Deal

Arteris’ FlexGen smart NoC IP will be used by AMD in semiconductor designs to enhance product performance and efficiency.

The company added that FlexGen will provide high-performance data transport in AMD chiplets, powering artificial intelligence (AI) across the latter’s broad portfolio spanning data centers to edge and end devices.

The agreement expands the relationship between the two companies, with Arteris’ technology now set to play a vital role in AMD’s broad AI computing portfolio. A deal with a large chip company like AMD is expected to boost Arteris’ prospects.

Deal Ahead of Q2 Earnings

Interestingly, this deal comes ahead of the Q2 earnings of both companies. Arteris is scheduled to announce its second-quarter results after the market closes on Tuesday, August 5. Wall Street expects Arteris to report a slightly narrower loss per share of $0.10 compared to $0.11 in the prior-year quarter. Revenue is expected to rise 11.6% year-over-year to $16.27 million.

Meanwhile, all eyes are on Advanced Micro Devices’ Q2 results on August 5. Wall Street expects AMD to report earnings per share (EPS) of $0.48, reflecting a 30% year-over-year decline. Meanwhile, revenue is estimated to grow by 27% to $7.41 billion.   

Wall Street’s Ratings on AIP and AMD Stocks

Analysts have a Strong Buy consensus rating on Arteris stock based on three unanimous Buys. The average AIP stock price target of $14 indicates 48.2% upside potential from current levels. AIP stock is down 7.3% year-to-date.

Meanwhile, Wall Street has a Moderate Buy consensus rating on Advanced Micro Devices stock based on 24 Buys, 10 Holds, and one Sell recommendation. The average AMD stock price target of $156.47 indicates a downside risk of 11.5% from current levels.

Disclaimer & DisclosureReport an Issue

1